ofa tirzepatide lawsuit FDA confirms shortage is still over, gives compounders a grace period Lilly files lawsuits over unauthorized

Clinical Trial Results Clinical trials have highlighted its efficacy, with participants experiencing significant weight reductions: Mounjaro Study Results: The SURMOUNT-1 trial (NEJM 2022) showed individuals with obesity losing up to 2022.5% of their body weight, surpassing many other weight-loss drugs in the market

Mounjaro can help reduce inflammation and metabolic dysfunction (i.e., insulin and leptin resistance) and has been associated with a reduction in blood pressure and improved cardiovascular health

| SandsRx Pharmacy

This is the period where decisions about long-term treatment, dose maintenance, and lifestyle sustainability become most relevant